Clinical Trial

Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence

Study acronym: Bioanatoner
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 16, 2023 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Biofeedback therapy is an effective treatment for the management of patients with dyssynergic defecation and constipation, urinary incontinence (UI), and fecal incontinence (FI). It is labor-intensive, costly, requires multiple office or hospital visits, is not easily available to the vast majority of patients in the community, and is not covered by many insurance companies. The purpose of this study is to 1. Evaluate home biofeedback therapy for patients with either constipation and dyssynergic defecation or urinary leakage or stool leakage by assessing the efficacy and safety of a wireless anorectal biofeedback device, and a cellphone app-based and voice guided home biofeedback training system 2. To compare the efficacy and safety of home biofeedback therapy system with the standard of care, office biofeedback therapy 3. To assess the cost-effectiveness of home biofeedback therapy.
Trial Details
NCT Number NCT05771597
Lead Sponsor Augusta University
Conditions Fecal Incontinence, Dyssynergic Defecation, Urinary Incontinence
Enrollment 72 participants
Start Date 2023-03-27
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-03-16